Human coronaviruses (HCoV) NL63 and HCoV-HKU1 have been identified but few studies have evaluated infection rates. Our institution began routine testing for HCoV-NL63 and HCoV-HKU1 in the fall of 2011 giving us the opportunity to determine the prevalence of infection. A retrospective analysis of 1,163 respiratory specimens submitted to Loyola University for evaluation using the Idaho Technology FilmArray Respiratory Pathogen array (BioFire Diagnostics, Salt Lake City, UT) from November 1, 2011, to April 15, 2012, and medical chart review was performed with approval by the institutional review board. Of all respiratory specimens submitted, 36 (3.1%) were positive for a HCoV with 16 positive for HCoV-NL63 (1.4%) and 20 positive for HCoV-HKU1 (1.7%). HCoV infection rate was highest in those less than 3 years of age (28; 77.8%), however HCoV-HKU1 showed a binodal distribution with another peak of infection for those aged 16-65 years (6 patients). A total of 19 patients (52.8%) had at least one additional virus detected with respiratory syncytial virus being most prevalent (10; 52.6%). Of those 36 HCoV positive patients, 19 (52.3%) patients were hospitalized and 10 (52.6%) had a coinfection. The in-patients with HCoV infection were more likely to be infected with HCoV-NL63 (7 patients) than HCoV-HKU1 (3 patients). While most studies have focused on HCoV-NL63 infection rates of pediatric in-patient populations, these data show that HCoV-NL63 infection and coinfection is common in the ambulatory population. Furthermore, our work shows that HCoV-HKU1 may play a larger role in the adult ambulatory population and contribute to physician visits. Continued surveillance is necessary to determine the role HCoVs play in both the in-patient and ambulatory population. In addition, physicians should be aware of emerging HCoVs such as HCoV-EMC, which has been implicated in the deaths of several patients in the Middle East.
